Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01634477Completed

Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study

Role: collaborator

NCT01634607Completed

Bone Health and Vitamin D Status

Role: collaborator

NCT01296373Completed

A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection

Role: collaborator

NCT00947609Completed

Improving Latent Tuberculosis (TB) Diagnosis in Thai Children

Role: collaborator

All 4 trials loaded